Our ovarian PDXs were developed from chemotherapy-naïve tumors showing marginal infiltration of human immune cells (minimal CD45 staining, Supplementary Figure S3); thus, we observed a particularly low incidence of EBV-associated lymphomas. This evidence concerns the gene PTPRC and lymphoma.